Drugs Manufacturer from Hyderabad on overdrive

Optimus Pharma gets DCGI nod for conducting Phase III Clinical Trials for Molnupiravir on patients with mild and moderate COVID-19 infection

Hyderabad (Telangana) [India], May 19: Optimus Pharma on Tuesday received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild and Moderate Covid-19 symptoms. With a severe shortage of antiviral drugs in the market against the SARS-CoV-2 infection, it is imperative that more drugs with potent antiviral activity against SARS-CoV-2 be introduced.

Optimus pharma said having internally developed the active pharmaceutical ingredient (API) and the formulations for the product, it had filed for clinical trials with the DCGI. The regulator gave a nod for conducting the trial on mild and moderate patients on May 18 2021.

As per the clinical trial, protocols approved, a total of 2500 subjects in both mild and moderate COVID-19 will be randomised in the study in a 1:1 ratio to Molnupiravir with standard supportive care or standalone standard supportive care. The treatment duration is a maximum of 05 days and the total study duration will be a maximum for 29 days from randomisation, the release said.

“Optimus is all geared to immediately begin clinical trials on Molnupiravir on COVID-19 patients in India. The clinical trial will let us know the efficacy of this molecule on COVID-19 patients,” Chairman & Managing Director – Dr. D Srinivas Reddy said.

In the previous press release, the company stated that Molnupiravir demonstrated highly promising results in reducing viral load to 0.0% in merely 5 days of treatment duration. Based on completed phase 2 part clinical studies, the proposed dosage is 800mg twice daily which significantly reduces viral culture in infected patients not progressing into ARDS.

Optimus Pharma is one of the largest manufacturers of the highly successful SARS-CoV-2 antiviral drug without compromising on quality as is the case with Favipiravir (sold under the brand – FAVICOVID).  The company aims to do the same with Molnupiravir to cater to the rising demand for Anti-Viral drugs against SARS-CoV-2 in the Indian market.

With the cooperation of the government and our stakeholders, and a special thanks to the Subject Expert Committee of the CDSCO for their valuable contribution and their recommendations to the project, we hope to deliver the product in India by leveraging our solid distribution strength across the country.

  • Related Posts

    • Health
    • July 18, 2024
    • 5 views
    Revolutionary Hair Growth Solution PEP-GF 9/4 Developed by Dr. Ayesha Faizan at Indian Skin Clinic

    New Delhi (India), July 18: Indian Skin Clinic, recognized as the best hair treatment clinic in Nagpur, is so happy to announce that the trademark for the PEP-GF 9/4 hair…

    • Health
    • July 16, 2024
    • 10 views
    Respiratory disease burden highest in India, COPD one of the fastest growing respiratory diseases: SMSRC

    New Delhi (India), July 16:   SMSRC & Group (Medclin Research and Synaegis), one of India’s leading healthcare research, intelligence & consulting organizations has published findings on major disease trends prevailing in…

    You Missed

    Celebrating Excellence at 2nd Annual World Influencers Day: Honoring Influencers, Solopreneurs, and Community Builders on 9th July

    • By
    • July 20, 2024
    Celebrating Excellence at 2nd Annual World Influencers Day: Honoring Influencers, Solopreneurs, and Community Builders on 9th July

    Fame Finders Media Unveils India’s Top Inspiring Coaches to Follow in 2024

    • By
    • July 20, 2024
    Fame Finders Media Unveils India’s Top Inspiring Coaches to Follow in 2024

    Attaining ascetic life is only possible through great fortune: Acharya Shri Mahashraman

    • By
    • July 19, 2024
    Attaining ascetic life is only possible through great fortune: Acharya Shri Mahashraman

    ‘’A Symbol of Inspiration: Smriti Mandhana’s Jersey Number 18’’ 

    • By
    • July 18, 2024
    ‘’A Symbol of Inspiration: Smriti Mandhana’s Jersey Number 18’’ 

    Does Select Shaadi Really Select The Right Partner For You?….. Reviews From Real Users

    • By
    • July 17, 2024
    Does Select Shaadi Really Select The Right Partner For You?….. Reviews From Real Users

    Naznin Khan: A Journey from Surat to Stardom

    • By
    • July 17, 2024
    Naznin Khan: A Journey from Surat to Stardom